News / Press – Diomics

Home
|
Category: News / Press

Diomics Corporation and Bonne Santé Group Announce Strategic Alliance Agreement

Agreement Calls for the Development and Distribution of the Diocare™ Best of Nature Products ...

Diomics Corporation Adds Industry Heavyweight, Former Amway Coo To Its Board Of Directors

Anthony Zolezzi, CEO of Diomics Corporation, is pleased to welcome Bill Nicholsonto the Diomics ...

A Human Antibody Nasal Spray Under Development Might Have Prevented White House Infections, Scientists At Diomics And Active Motif Say

Antibody Barrier in the Nasal Cavity Could Hold A Key to Curtailing Virus SpreadSAN ...

Diomics Announces Agreement with Department of Defense to Accelerate Development and Testing of Diocheck™ SARS-CoV-2 Immune Response Indicator Patch

Simple Skin Patch Empowers Individuals to Monitor for Immune Response to Help Stop COVID-19 ...

Diomics Aims to Nose Out Coronavirus Ahead of Vaccines With Nasal Spray That Delivers Monoclonal Antibody Protection

Unique Prophylactic Approach Couples IgG Antibodies from Active Motif with Diomics’ Proprietary Bioresorbable Polymer ...

Diomics Announces Development Of Diocheck™ Visual Antibody Indicator

Proprietary Diomat™ Technology Enables Long-Term Antibody Detection to Assist in COVID-19 MonitoringSAN DIEGO, CALIF., August ...